Does multi-scale symbolic entropy analysis provide prognostic prediction in patients receiving extracorporeal life support?
MSsE provides additional prognostic information in patients receiving ECLS.
Subconjunctival bevacizumab and ranibizumab treatments may be effective methods in reducing corneal neovascularization. Furthermore, bevacizumab is more effective than ranibizumab in the inhibition of corneal neovascularization.